Skip to main content

Implantable drug infusion system

10
Feb 2025

Recommendations about add-on reimbursement for medical devices in France in January 2025

The French National Authority for Health (HAS) has released new recommendations about add-on reimbursement of medical devices and medical aids from the January 2025 meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Seventeen favorable opinions were published concerning the registration or modification of registration conditions/extension of indications for the medical devices in the List of Reimbursable Products and Services (LPPR). They relate to cardiovascular, endocrine, e-health, interventional radiology, neurology and neurosurgery, orthopedic devices, and medical aids.
21
May 2019

MTRC has released European reimbursement report for implantable drug infusion systems for chronic pain in 11 EU countries

The report presents a summary of reimbursement situation report for implantable drug infusion systems for chronic pain. The following indications will be considered: post-laminectomy syndrome, low back pain, complex regional pain syndrome, neoplasm related pain. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.